HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Troxipide
KU 54 · Aplace · TROXIPIDE · Troxipide RS · Troxipide API · Troxipide Troxipide · Troxipide - Bio-X ? · TROXIPIDE 98.5% MIN
Identifikatoren & physikalische Daten
| CAS No. | 30751-05-4 |
|---|---|
| Summenformel | C15H22N2O4 |
| Durchschnittliche Molmasse | 294,35 g/mol |
| Monoisotopische Masse | 294,15795718 g/mol |
| SMILES | COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC |
| InChIKey | YSIITVVESCNIPR-UHFFFAOYSA-N |
| PubChem CID | 5597 |
| ChEMBL | CHEMBL1566956 |
| ChEBI | CHEBI:32271 |
| EC No. | 805-913-5 |
| DTXSID | DTXSID2023725 |
Chemische & physikalische Eigenschaften
| XLogP | 1,2 |
|---|---|
| Polarare Oberfläche (TPSA) | 68,8 |
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 5 |
| Frei drehbare Bindungen | 5 |
| Schwere Atome | 21 |
| Formalladung | 0 |
| Komplexität | 326 |
| Schmelzpunkt | 177.0 to 181.0 °C |
| Siedepunkt | 407.5±45.0 °C(Predicted) |
| Dichte | 1.18±0.1 g/cm3(Predicted) |
| Lagerbedingungen | under inert gas (nitrogen or Argon) at 2–8 °C |
| Löslichkeit | Acetonitrile (Slightly), Chloroform (Slightly), Methanol (Slightly) |
| Aggregatzustand | Solid |
| pKa (Säurekonstante) | 13.66±0.20(Predicted) |
| Farbe | White to Off-White |
| CAS Datenbank | 30751-05-4(CAS DataBase Reference) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Skin Irrit. 2 (100%) |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)TroxipideDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
| Zollcode | 2933.39.9200 |
| RTECS-Nr. | CV5792600 |
Anwendungen & Verwendung
Beschreibung
Troxipide is an antiulcer agent which is suggested to actvia beneficial effects on gastric glycoprotein metabolism and blood flow.
Verwenden
Troxipide is a drug used in the treatment of gastroesophageal reflux disease. It is capable of inhibiting the chemotactic migration and superoxide generation in the gastric mucosa.